Analyst Price Target Update on Mead Johnson Nutrition Company (NYSE:MJN)

Mead Johnson Nutrition Company (NYSE:MJN): 6 Analyst have given the stock of Mead Johnson Nutrition Company (NYSE:MJN) a near short term price target of $80.67. The standard deviation reading, which is a measure by which the stock price is expected to swing away from the mean estimate, is at $6.89. The higher price target estimate is at $89 while the lower price estimates are fixed at $70.

Many analysts have stated their opinion on the company shares. In a research note released to the investors, Citigroup maintains its rating on Mead Johnson Nutrition Company (NYSE:MJN).The analysts at the brokerage house have a current rating of Buy on the shares. In a recent information released to the investors, Citigroup raises the new price target from $85 per share to $100 per share. The rating by the firm was issued on April 18, 2016. Company shares have received an average consensus rating of Hold for the current week

On the companys insider trading activities, According to the information disclosed by the Securities and Exchange Commission in a Form 4 filing, the officer (SVP and President, Asia) of Mead Johnson Nutrition Co, Stratton Christoper Richard had sold 33,730 shares worth of $2,923,716 in a transaction dated May 2, 2016. In this transaction, 33,730 shares were sold at $86.68 per share.

Mead Johnson Nutrition Company (NYSE:MJN) stock ended Monday session in the red zone in a volatile trading. The stock closed down 0.27 points or 0.32% at $83.52 with 1,504,383 shares getting traded. Post opening the session at $83.6, the shares hit an intraday low of $82.56 and an intraday high of $83.79 and the price was in this range throughout the day. The company has a market cap of $15,590 million and the number of outstanding shares have been calculated to be 186,663,920 shares. The 52-week high of Mead Johnson Nutrition Company (NYSE:MJN) is $93.07 and the 52-week low is $65.53.

Mead Johnson Nutrition Company (Mead Johnson) is a global pediatric nutrition company. The Company manufactures, distributes and sells infant formulas, childrens nutrition and other nutritional products. Its product portfolio includes routine and specialty infant formulas, childrens milks and milk modifiers, dietary supplements for pregnant and breastfeeding mothers, pediatric vitamins, and products for pediatric metabolic disorders. The Company operates through three segments: Asia, Latin America and North America/Europe. The Companys Enfa family of brands, including Enfamil infant formula, is a brand franchise in pediatric nutrition. Its product portfolio addresses a range of nutritional needs for infants, children and expectant and nursing mothers. The Company markets its portfolio of more than 70 products to mothers, healthcare professionals and retailers in more than 50 countries in Asia, North America, Latin America and Europe.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.